Active [3H]-dopamine uptake displayed by native lymphocyte suspensions is mainly due to contaminating platelets

Pharmacopsychiatry

Volumn 31, Issue 5, 1998, Pages 193-198

  Krieger, K ^a,b   Klimke, A ^a   Henning, U ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE; IMIPRAMINE; SEROTONIN TRANSPORTER; TRITIUM; VANOXERINE;

ARTICLE; B LYMPHOBLAST; CELL SUSPENSION; CONTAMINATION; CONTROLLED STUDY; DOPAMINE UPTAKE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOCYTE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; T LYMPHOBLAST; THROMBOCYTE; VIRUS CELL TRANSFORMATION; CELL LINE; CELL SEPARATION; COMPARATIVE STUDY; METABOLISM;

BLOOD PLATELETS; CELL LINE, TRANSFORMED; CELL SEPARATION; DOPAMINE; HUMANS; LYMPHOCYTES; TRITIUM;

EID: 0031593405     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979326     Document Type: Article

References (49)

1. 3H-GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. J. of Neurochemistry 48 (1987) 1887-1896
2. 5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine? Neurosci. Lett. 207 (1996) 73-76
3. Bergquist, J., E. Josefson, A. Tarkowski, R. Ekman, A. Ewing: Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis. Electrophoresis 18 (1997) 1760-1766
4. 3H-spiperone to human lymphocytes: a biological marker in schizophrenia? Psychiatry Res. 15 (1985) 41-48
5. 3H-spiperone binding to lymphocytes: reality or artefact. Pharmacopsychiatry 24 (1991) 35-36
6. Bondy, B., M. Ackenheil, T. Ruppert: Spiperone binding in lymphocytes: part of a dopamine uptake system? Ann. N. Y. Acad. Sci. 650 (1992) 221-225
7. 3H-spiperone binding in mononuclear cells: a family study. Prog. Neuropsychopharmacol. Biol. Psychiatry 17 (1993) 373-381
8. 4 receptor mRNA in circulating human lymphocytes using nested polymerase chain reaction. J. Neuroimmunol. 71 (1996) 139-144
9. Böyum, A.: Isolation of mononuclear cells and granulocytes from human blood: Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Invest. 97 (Suppl.) (1976) 77
10. 2 receptors, in rat and human lymphocytes. Immunopharmacology 22 (1991) 93-105
11. 2 receptor. Life Sciences. 45 (1989) 401-411
12. 3H-dopamine uptake by platelets from subjects with active schizophrenia. Psychiatry Res. 41 (1990a) 17-24
13. 3H-dopamine by human platelets. Clinica Chimica Acta. 187 (1990b) 37-46
14. 11C-raclopride. Arch. Gen. Psychiatry 47 (1990) 213-219
15. 3H-dopamine uptake by human lymphocytes: correlates with serotonin transporter activity. Pharmacology 48 (1994) 320-327
16. Faraj, B. A., Z. L. Olkowski, R. T. Jackson: A cocaine-sensitive active dopamine transport in human lymphocytes. Biochem. Pharmacol. 50 (1995) 1007-1014
17. Gandolfi, O., M. L. Barbaccia, E. Costa: Comparison of iprindole, imipramine and mianserin action on brain serotonergic and ß adrenergic receptors. J. Pharmacol. Exp. Ther. 229 (1984) 782-786
18. 3H-spiperone by lymphocytes in schizophrenics and their first-degree relatives: a limited vulnerability marker? J. Psychiatry Res. 26 (1992) 77-84
19. Halbach, M., U. Henning, B. Riese, P. Kern, G. Scheidt: Blutzellmarker als Laborkriterien für Diagnostik und Verlaufsbeobachtungen schizophrener Psychosen. In: K. Heinrich, E. Klieser & E. Lehmann (Hrsg.): Prädiktoren des Therapieverlaufs endogener Psychosen. Stuttgart: Schattauer (1993) 149-162
20. 3H-(+)-amphetamine binding sites in the rat central nervous system. Life Sci. 28 (1981) 445-450
21. Heikkila, R. E., L. Manzino: Behavioral properties of GBR-12 909, GBR-13 069 and GBR-13 098: specific inhibitors of dopamine uptake. Eur. J. Pharmacol. 103 (1984) 241-248
22. Hjorth, R., A.-K. Jonsson, P. Vretblad: A rapid method for purification of human granulocytes using percoll. A comparison with dextran sedimentation. J. of Immunological Methods 43 (1981) 95-101
23. 3H-spiperone by lymphocytes in schizophrenia. J. Psychiatry Res. 23 (1991) 221-227
24. Koutsilieri, E., J. Kornhuber, H. J. Degen, K. P. Lesch, S. Sopper, V. ter Meulen, P. Riederer: U-373 MG glioblastoma and IMR-32 neuroblastoma cell lines express the dopamine and vesicular monoamine transporters. J. Neurosci. Res. 45 (1996) 269-275
25. Krieger, K., U. Henning, M. Halbach: Zur Natur der Spiperon-Bindung auf Lymphozyten. Fortschr. Neurol. Psychiatr. 62 (S2) (1994) 116
26. Lesch, K. P., B. L. Wolozin, D. L. Murphy, P. Riederer: Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J. Neurochem. 60 (1993) 2319-2322
27. Mathysse, S.: Antipsychotic drug action: A clue to the neuropathology of schizophrenia? Fed. Proc. 32 (1973) 200-205
28. Neitzel, H.: A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum. Genet. 73 (1986) 320-326
29. Omenn, G. S., L. T. Smith: A common uptake system for serotonin and dopamine in human platelets. J. Clin. Invest. (1978) 235-240
30. Pappenheimer, A. M.: Experimental studies upon lymphocytes: I. The reactions of lymphocytes under various experimental conditions. J. Exp. Med. 25 (1917) 633
31. 2 dopamine receptor PET and structural MRI changes in late-onset schizophrenia. Schizophr. Bull. 19 (1993) 783-795
32. 3H]Dopamine uptake by platelet storage granules in schizophrenia. Life Sciences 50 (1992) 65-72
33. Randrup, A., I. Munkvad, R. Fog, J. Gerlach, L. Molander, B. Kjellberg, J. Scheel-Krüger: Mania, depression and brain dopamine. In: Essman W. B., Valzelli L. (eds.): Current developments in Psychopharmacology, Vol. 2. Spectrum, New York (1975) 206-248
34. Rao, M. L., A. Deister, A. Roth: Lymphocytes of healthy subjects and schizophrenic patients possess no high-affinity binding sites for spiroperidol. Pharmacopsychiatry 23 (1990) 176-181
35. Richards, M. L., W. Sadee: Human neuroblastoma cell lines as a model of catechol uptake. Brain Res 384 (1986) 132-137
36. 3H-7-OH-DPAT. J. Neuroimmunol. 58 (1995) 13-144
37. Roos, D., J. A. Loos: Changes in the carbohydrate metabolism of nitrogenically stimulated human peripheral lymphocytes. Stimulation by phythaemagglutinin. Biochem. Biophys. Acta 22 (1970) 565-582
38. Rossi, E. C.: The effect of albumin upon the loss of enzymes from washed platelets. J. Lab. Clin. Med. 79 (1972) 240-246
39. Rotman, A., H. Munitz, J. Modai, S. Tjano, H. Wijsenbeek: A comparative uptake study of serotonin, dopamine and norepinephrine by platelets of acute schizophrenic patients. Psychiatry Res. 3 (1980) 239-246
40. Santambrogio, L., M. Lipartiti, A. Bruni, R. Dal Toso: Dopamine receptors on human T-and B-lymphocytes. J. Neuroimmunol. 45 (1993) 113-119
41. Solomon, H. M., N. M. Spint, W. B. Abrams: The accumulation and metabolism of dopamine in the human platelet. Clin. Pharmacol. Ther. 11 (1970) 838-845
42. Stahl, S. M., H. Y. Meltzer: The human platelet as a model for the dopaminergic neuron: kinetic and pharmacological properties and the role of amine storage granules. Exp. Neurol. 59 (1978) 1-15
43. 3H-dopamine uptake by washed platelets provides no evidence for circulating inhibitors of platelet dopamine uptake in schizophrenia. Biol. Psychiatry. 36 (1994) 595-600
44. Tumilowicz, J. J., W. W. Nichols, J. J. Cholon, A. E. Greene: Definition of a continuous human cell line derived from neuroblastoma. Cancer Res. 30 (1970) 2110-2118
45. van Rossum, J. M.: The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch. Int. Pharmacodyn. Ther. 160 (1966) 492-494
46. Volkow, N. D., G. J. Wang, J. S. Fowler, J. Logon, S. J. Gatley, R. Hitzemann, A. D. Chen, S. L. Dewey, N. Pappas: Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386 (6627) (1997) 830-833
47. 2-like dopamine receptors are not detectable on human peripheral blood lymphocytes. Biol. Psychiatry 40 (1996) 881-885
48. 3H] tolyl)-guanidine: A selective ligand that labels σ-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc. Natl. Acad. Sci. 83 (1986) 8784-8788
49. 2 dopamine receptors in drug-naive schizophrenics. Science 234 (1986) 1558-1563